Joseph Zabinski

Company: OM1 Inc

Job title: Vice President, Commercial Strategy & AI

Seminars:

Beyond BMI: Using AI-Based Phenotyping to Understand GLP-1 Treatment Outcomes Across the Patient Journey 4:45 pm

Identifying positive and negative impacts of GLP-1 treatment across organ systems using real-world data Using AI-based digital phenotyping to isolate distinct patient profiles based on likely outcomes, before and during treatment Assessing the balance among different treatment effects for personalized decision-makingRead more

day: Conference Day One